Evidence map›Paper›PMID 31338535›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2019

Agonists activate different A

Marthe Koussémou, Karl-Norbert Klotz

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Adenosine receptors in breast cancer.Molecular biology reports · 2024
    Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marthe KoussémouInstitut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Str. 9, 97078, Würzburg, Germany.
Karl-Norbert KlotzInstitut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Str. 9, 97078, Würzburg, Germany. klotz@toxi.uni-wuerzburg.de.ORCID http://orcid.org/0000-0003-3553-3205
University of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well established that some receptor types including G protein-coupled receptors may transduce effects through more than one signaling pathway. This holds also true for A

Indexed as

Adenosine A2 Receptor AgonistsAdenylyl CyclasesBreast NeoplasmsCalciumCell Line, TumorCyclic AMPHumansMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphorylationReceptor, Adenosine A2BSignal TransductionAdenosine A2 Receptor AgonistsAdenylyl CyclasesCalciumCyclic AMPMAPK1 protein, humanMAPK3 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Receptor, Adenosine A2BA2BAdenosine receptorAgonistPotencySignaling bias

Identifiers

PMID31338535
OpenAlexW2962782007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.